TRIP suppresses cell proliferation and invasion in choroidal melanoma via promoting the proteasomal degradation of Twist1

AbstractChoroidal melanoma (CM) remains the most prevalent form of intraocular malignancy, and the prognosis of affected patients is poor. While the E3 ubiquitin ligase TRIP is known to play key regulatory roles in multiple diseases, its relevance in CM remains uncertain. In the present study, we found that TRIP overexpression is sufficient to inhibit the proliferation, invasion, and EMT of CM cellsin vitro, whereas the opposite phenotypes are observed following TRIP knockdown. We further determined that TRIP is able to promote the K48 ‐polyubiquitination of EMT‐associated transcription factor Twist1, thereby suppressing EMT progression. Together, our results suggest that TRIP plays an important role in regulating the progression of CM and that it may, therefore, be an important therapeutic target for the treatment of this dis ease.

Source: FEBS Letters - July 7, 2020 Category: Biochemistry Authors: Chao Wei, Xiaofei Zhao, Lei Wang, Han Zhang Tags: RESEARCH ARTICLES Source Type: research